Literature DB >> 9564044

A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host.

M Wiese1.   

Abstract

The parasitic protozoon Leishmania mexicana undergoes two major developmental stages in its life cycle exhibiting profound physiological and morphological differences, the promastigotes in the insect vector and the amastigotes in mammalian macrophages. A deletion mutant, Deltalmsap1/2, for the secreted acid phosphatase (SAP) gene locus, comprising the two SAP genes separated by an intergenic region of approximately 11.5 kb, lost its ability to cause a progressive disease in Balb/c mice. While in vitro growth of promastigotes, invasion of host cells and differentiation from promastigotes to amastigotes was indistinguishable from the wild-type, the mutant parasites ceased to proliferate when transformed to amastigotes in infected macrophages or in a macrophage-free in vitro differentiation system, suggesting a stage-specific growth arrest. This phenotype could be reverted by complementation with 6 kb of the intergenic region of the SAP gene locus. Sequence analysis identified two open reading frames, both encoding single copy genes; one gene product shows high homology to mitogen-activated protein (MAP) kinases. Complementation experiments revealed that the MAP kinase homologue, designated LMPK, is required and is sufficient to restore the infectivity of the Deltalmsap1/2 mutant. Therefore, LMPK is a kinase that is essential for the survival of L.mexicana in the infected host by affecting the cell division of the amastigotes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564044      PMCID: PMC1170603          DOI: 10.1093/emboj/17.9.2619

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  LEISHMANI MEXICANA: THE EPIDEMIOLOGY OF DERMAL LEISHMANIASIS IN BRITISH HONDURAS.

Authors:  R LAINSON; J STRANGWAYS-DIXON
Journal:  Trans R Soc Trop Med Hyg       Date:  1963-07       Impact factor: 2.184

Review 2.  Molecular determinants of Leishmania virulence.

Authors:  K P Chang; G Chaudhuri; D Fong
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Protein kinases in divergent eukaryotes: identification of protein kinase activities regulated during trypanosome development.

Authors:  M Parsons; M Valentine; V Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers.

Authors:  D T Hart; K Vickerman; G H Coombs
Journal:  Parasitology       Date:  1981-06       Impact factor: 3.234

5.  Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglycoprotein polymer.

Authors:  T Ilg; Y D Stierhof; R Etges; M Adrian; D Harbecke; P Overath
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana.

Authors:  V Bahr; Y D Stierhof; T Ilg; M Demar; M Quinten; P Overath
Journal:  Mol Biochem Parasitol       Date:  1993-03       Impact factor: 1.759

7.  Estimation of population at risk of infection and number of cases of Leishmaniasis.

Authors:  R W Ashford; P Desjeux; P Deraadt
Journal:  Parasitol Today       Date:  1992-03

Review 8.  MAP kinase and the activation of quiescent cells.

Authors:  J V Ruderman
Journal:  Curr Opin Cell Biol       Date:  1993-04       Impact factor: 8.382

9.  ATMPKs: a gene family of plant MAP kinases in Arabidopsis thaliana.

Authors:  T Mizoguchi; N Hayashida; K Yamaguchi-Shinozaki; H Kamada; K Shinozaki
Journal:  FEBS Lett       Date:  1993-12-28       Impact factor: 4.124

Review 10.  Trans splicing in trypanosomes--archaism or adaptation?

Authors:  P W Laird
Journal:  Trends Genet       Date:  1989-07       Impact factor: 11.639

View more
  52 in total

1.  Protein kinase involved in flagellar-length control.

Authors:  Martin Wiese; Daniela Kuhn; Christoph G Grünfelder
Journal:  Eukaryot Cell       Date:  2003-08

2.  Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.

Authors:  Mansi Garg; Shyam Sundar; Robert Duncan; Hira L Nakhasi; Neena Goyal
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.

Authors:  Goutam Mandal; Mansi Sharma; Martin Kruse; Claudia Sander-Juelch; Laura A Munro; Yong Wang; Jenny Veide Vilg; Markus J Tamás; Hiranmoy Bhattacharjee; Martin Wiese; Rita Mukhopadhyay
Journal:  Mol Microbiol       Date:  2012-07-26       Impact factor: 3.501

Review 4.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

5.  Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

Authors:  G F Späth; L Epstein; B Leader; S M Singer; H A Avila; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana.

Authors:  T Ilg
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

7.  Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro.

Authors:  Linda Reiling; Mareike Chrobak; Christel Schmetz; Joachim Clos
Journal:  Mol Microbiol       Date:  2010-03-25       Impact factor: 3.501

8.  Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection.

Authors:  Andrés F Flórez; Daeui Park; Jong Bhak; Byoung-Chul Kim; Allan Kuchinsky; John H Morris; Jairo Espinosa; Carlos Muskus
Journal:  BMC Bioinformatics       Date:  2010-09-27       Impact factor: 3.169

9.  Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.

Authors:  Shuang Wei; Benjamin J Daniel; Michael J Brumlik; Matthew E Burow; Weiping Zou; Imtiaz A Khan; Scott Wadsworth; John Siekierka; Tyler J Curiel
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

10.  Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors.

Authors:  Mahendra Awale; Vivek Kumar; Parameswaran Saravanan; C Gopi Mohan
Journal:  J Mol Model       Date:  2009-08-02       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.